AIG
TXMD icon

American International Group’s TherapeuticsMD TXMD Stock Holding History

American International Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,871
Closed -$74K – 3266
2022
Q1 		$74K Sell
3,871
-273
-7% -$4.29K ﹤0.01% 2706
2021
Q4 		$74K Sell
4,144
-124
-3% -$3.72K ﹤0.01% 2838
2021
Q3 		$158K Buy
4,268
+214
+5% +$9.5K ﹤0.01% 2572
2021
Q2 		$241 Buy
4,054
+123
+3% +$7.45K ﹤0.01% 2384
2021
Q1 		$263 Buy
3,931
+936
+31% +$73.3K ﹤0.01% 2212
2020
Q4 		$181 Buy
2,995
+170
+6% +$11.6K ﹤0.01% 2331
2020
Q3 		$223K Sell
2,825
-64
-2% -$5.1K ﹤0.01% 2084
2020
Q2 		$181K Buy
2,889
+267
+10% +$15.5K ﹤0.01% 2180
2020
Q1 		$139K Sell
2,622
-151
-5% -$15K ﹤0.01% 2115
2019
Q4 		$336K Buy
2,773
+285
+11% +$41K ﹤0.01% 1916
2019
Q3 		$452K Sell
2,488
-17
-0.7% -$2.4K ﹤0.01% 1723
2019
Q2 		$326K Buy
2,505
+151
+6% +$27.1K ﹤0.01% 1944
2019
Q1 		$573K Sell
2,354
-52
-2% -$13.8K ﹤0.01% 1626
2018
Q4 		$458K Sell
2,406
-18
-0.7% -$4.39K ﹤0.01% 1719
2018
Q3 		$795K Buy
2,424
+234
+11% +$71.7K ﹤0.01% 1593
2018
Q2 		$683K Buy
2,190
+72
+3% +$22K ﹤0.01% 1631
2018
Q1 		$516K Sell
2,118
-114
-5% -$32K ﹤0.01% 1701
2017
Q4 		$674K Buy
2,232
+139
+7% +$38.7K ﹤0.01% 1605
2017
Q3 		$554K Buy
2,093
+156
+8% +$45.1K ﹤0.01% 1706
2017
Q2 		$510K Buy
1,937
+89
+5% +$22.3K ﹤0.01% 1691
2017
Q1 		$665K Buy
1,848
+122
+7% +$37.8K ﹤0.01% 1416
2016
Q4 		$498K Sell
1,726
-5
-0.3% -$1.55K ﹤0.01% 1636
2016
Q3 		$589K Buy
1,731
+3
+0.2% +$1.1K ﹤0.01% 1518
2016
Q2 		$734K Sell
1,728
-158
-8% -$65.1K ﹤0.01% 1363
2016
Q1 		$603K Buy
1,886
+25
+1% +$8.53K ﹤0.01% 1859
2015
Q4 		$965K Buy
1,861
+222
+14% +$82K ﹤0.01% 1536
2015
Q3 		$480K Sell
1,639
-21
-1% -$7.46K ﹤0.01% 2061
2015
Q2 		$652K Buy
1,660
+215
+15% +$75.9K ﹤0.01% 1940
2015
Q1 		$437K Hold
1,445
– – ﹤0.01% 2266
2014
Q4 		$322K Buy
1,445
+20
+1% +$4.13K ﹤0.01% 2527
2014
Q3 		$331K Sell
1,425
-35
-2% -$8.82K ﹤0.01% 2498
2014
Q2 		$323K Buy
1,460
+228
+19% +$50.7K ﹤0.01% 2571
2014
Q1 		$389K Buy
1,232
+42
+4% +$13.4K ﹤0.01% 2274
2013
Q4 		$310K Buy
1,190
+144
+14% +$31.5K ﹤0.01% 2385
2013
Q3 		$153K Buy
+1,046
New +$126K ﹤0.01% 2956

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

American International Group's TXMD Position: Q2 2022 in Review

American International Group sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 3,871 shares — an estimated $74K sold.

American International Group first reported a position in TXMD in Q3 2013 and held it in 35 quarters. The position peaked at $965K in Q4 2015. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • American International Group reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 3,871 TherapeuticsMD shares in Q2 2022, an estimated $74K.
  • American International Group first reported a position in TherapeuticsMD in Q3 2013 and held it in 35 quarters.
  • American International Group's TherapeuticsMD position peaked at $965K in Q4 2015.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.